Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Shane J. Schaffer, Pharm.D.$4M
Market Cap • 25/07/20242021
(há 3 anos)
2021
(3 years ago)
NASDAQ
Listagem
Kansas
Sede • Kansas15
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
CINGSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.